Gastric Cancer Clinical Trials in Ho Chi Minh City
6 recruitingHo Chi Minh City, Vietnam
Showing 1–6 of 6 trials
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Gastroesophageal Junction AdenocarcinomaHER2-positive Gastric Cancer
AstraZeneca840 enrolled284 locationsNCT06764875
Recruiting
Phase 3
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Gastric CancerGastroesophageal-junction Cancer
AstraZeneca572 enrolled186 locationsNCT06346392
Recruiting
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Breast CancerLiver CancerColorectal, Cancer+4 more
Gene Solutions50 enrolled2 locationsNCT06227728
Recruiting
Not Applicable
Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer
Gastric Cancer
University Medical Center Ho Chi Minh City (UMC)210 enrolled3 locationsNCT06202105
Recruiting
Not Applicable
Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric Cancer
Gastric CancerDistal Gastrectomy
University Medical Center Ho Chi Minh City (UMC)320 enrolled1 locationNCT05344339